BioNTech waited to collect its $100M PRV until just before Moderna’s Covid-19 vaccine approval

The FDA on Friday released a new letter sent last week to BioNTech and Pfizer regarding their quietly held priority review voucher. Despite the fact that the company could’ve collected the voucher after winning approval for their Covid-19 vaccine in August, the letter was released just a day after BioNTech’s...

Click to view original post